Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

ClinicalTrials.gov ID: NCT01605227

Public ClinicalTrials.gov record NCT01605227. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 12:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Controlled Study of Cabozantinib (XL184) Versus Prednisone in Metastatic Castration-resistant Prostate Cancer Patients Who Have Received Prior Docetaxel and Prior Abiraterone or MDV3100

Study identification

NCT ID
NCT01605227
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Exelixis
Industry
Enrollment
1,028 participants

Conditions and interventions

Interventions

  • cabozantinib Drug
  • prednisone Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2012
Primary completion
Aug 31, 2014
Completion
Feb 28, 2015
Last update posted
Mar 13, 2018

2012 – 2015

United States locations

U.S. sites
77
U.S. states
35
U.S. cities
76
Facility City State ZIP Site status
Not listed Birmingham Alabama 35205
Not listed Anchorage Alaska 99508
Not listed Phoenix Arizona 85016
Not listed Scottsdale Arizona 85255
Not listed Tucson Arizona 85710
Not listed Jonesboro Arkansas 72401
Not listed Duarte California 91010
Not listed Highland California 92346
Not listed La Jolla California 92093
Not listed Los Angeles California 90033
Not listed Montebello California 90640
Not listed Orange California 92868
Not listed Palo Alto California 94301
Not listed Rancho Mirage California 92270
Not listed San Marcos California 92069
Not listed St. Helena California 94574
Not listed Vallejo California 94589
Not listed Aurora Colorado 80045
Not listed New Haven Connecticut 06520
Not listed Southington Connecticut 06489
Not listed Miami Beach Florida 33140
Not listed Ocala Florida 34471
Not listed Orlando Florida 32806
Not listed Tampa Florida 33612
Not listed Titusville Florida 32796
Not listed Wellington Florida 33449
Not listed West Palm Beach Florida 33401
Not listed Athens Georgia 30607
Not listed Atlanta Georgia 30318
Not listed Marietta Georgia 30060
Not listed Galesburg Illinois 61401
Not listed Niles Illinois 60714
Not listed Ames Iowa 50010
Not listed Sioux City Iowa 51101
Not listed Wichita Kansas 67214
Not listed Hazard Kentucky 41701
Not listed Louisville Kentucky 40202
Not listed Brewer Maine 04412
Not listed Baltimore Maryland 21201
Not listed Bethesda Maryland 20817
Not listed Towson Maryland 21204
Not listed Boston Massachusetts 02114
Not listed Boston Massachusetts 02118
Not listed Methuen Massachusetts 01844
Not listed Detroit Michigan 48202
Not listed Wyoming Michigan 49509
Not listed Minneapolis Minnesota 55455
Not listed Jefferson City Missouri 65109
Not listed Springfield Missouri 65804
Not listed Lincoln Nebraska 68506
Not listed Omaha Nebraska 68130
Not listed Hackensack New Jersey 07601
Not listed Lawrenceville New Jersey 08648
Not listed Albany New York 12208
Not listed Garden City New York 11530
Not listed New York New York 10065
Not listed Pinehurst North Carolina 28374
Not listed Bismarck North Dakota 58501
Not listed Cincinnati Ohio 45219
Not listed Columbus Ohio 43221
Not listed Portland Oregon 97227
Not listed Bryn Mawr Pennsylvania 19010
Not listed Hershey Pennsylvania 17033
Not listed Lancaster Pennsylvania 17604
Not listed Greenville South Carolina 29615
Not listed Chattanooga Tennessee 37421
Not listed Amarillo Texas 79106
Not listed Bedford Texas 76022
Not listed Houston Texas 77024
Not listed Laredo Texas 78041
Not listed San Antonio Texas 78217
Not listed Salt Lake City Utah 84112
Not listed Burlington Vermont 05405
Not listed Fairfax Virginia 22031
Not listed Newport News Virginia 23601
Not listed Spokane Washington 99204
Not listed Green Bay Wisconsin 54311

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 187 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01605227, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 13, 2018 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01605227 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →